My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Organon & Co. Common Stock (NY:OGN)

7.140 UNCHANGED

Official Closing Price Updated: 7:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2023 ↗

September 21, 2023

Via Benzinga

First Real-World Observational Study of the JADA® System, a Medical Device to Control Postpartum Hemorrhage (PPH), Published in ACOG’s Obstetrics & Gynecology

September 14, 2023

From Organon & Co.

Via Business Wire

Organon's Return On Capital Employed Insights ↗

May 15, 2023

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

May 15, 2023

Via Benzinga

Organon's Earnings: A Preview ↗

May 03, 2023

Via Benzinga

3 Pharmaceutical Stocks That Are Too Cheap to Ignore ↗

September 09, 2023

Viatris, GSK, and Organon are all trading at less than 7 times earnings.

Via The Motley Fool

Stock Analysis: Organon & Co. ↗

September 07, 2023

Organon & Co. sells its products to drug wholesalers, retailers, hospitals, pharmacies, clinics, government agencies, and other institutions worldwide.

Via Talk Markets

Organon Bolsters Research & Development Expertise with Two Leadership Appointments

September 05, 2023

From Organon & Co.

Via Business Wire

3 Undervalued Healthcare Stocks In 2023 ↗

August 31, 2023

These 3 undervalued healthcare stocks in 2023 are attractive today for their attractive valuations and total return potential.

Via Talk Markets

A Look Into Healthcare Sector Value Stocks ↗

August 14, 2023

Via Benzinga

Organon Reports Results for the Second Quarter Ended June 30, 2023

August 08, 2023

From Organon & Co.

Via Business Wire

5 Value Stocks In The Healthcare Sector ↗

August 07, 2023

Via Benzinga

Samsung Bioepis & Organon Announce Topline Results from Interchangeability Study of SB5 Humira Biosimilar

August 01, 2023

From Samsung Bioepis

Via GlobeNewswire

Overview Of Value Stocks In The Healthcare Sector ↗

July 31, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 24, 2023

Via Benzinga

Need an Extra $4,000 in Dividends Each Year? Invest $68,000 in These 3 Stocks. ↗

July 21, 2023

These stocks can significantly bolster your income.

Via The Motley Fool

Datadog, IQVIA, Organon And An Oilfield Services Giant Rolling Out An AI Platform: CNBC's 'Final Trades' ↗

July 17, 2023

On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said he likes IQVIA Holdings Inc. (NYSE: IQV)

Via Benzinga

Organon To Report Second Quarter Results and Host Conference Call on August 8, 2023

July 17, 2023

From Organon & Co.

Via Business Wire

REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator

July 05, 2023

From Organon

Via Business Wire

3 S&P 500 Stocks to Own for the Next 50 Years ↗

July 04, 2023

These three S&P 500 companies all buy and hold stocks for the next 50 years or more because they operate in attractive industries.

Via InvestorPlace

Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator

July 01, 2023

From Organon & Co.

Via Business Wire

Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks ↗

June 29, 2023

These stocks are down more than 5% this year, and now may be a good time to add them to your portfolio.

Via The Motley Fool

Organon Publishes FY2022 ESG Report Showcasing Progress Toward Global Sustainability Goals

June 27, 2023

From Organon & Co.

Via Business Wire

Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts ↗

June 26, 2023

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields ↗

June 08, 2023

Via Benzinga

Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women’s Health

June 07, 2023

From Organon & Co.

Via Business Wire

7 Stocks That Are Long Overdue for a Relief Rally ↗

May 18, 2023

Here are seven stocks with the catalysts and fundamentals to support a sustained relief rally in this environment.

Via InvestorPlace

Daily Stock Analysis: Organon & Co ↗

May 15, 2023

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions.

Via Talk Markets

Check Out 3 Health Care Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts ↗

May 09, 2023

Via Benzinga

Organon Reports Results for the First Quarter Ended March 31, 2023

May 04, 2023

From Organon & Co.

Via Business Wire

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.